A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial

NCT06215495 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Radiation Toxicity
MRI Simulated Positioning
High Grade Glioma
Progression-free Survival
Overall Survival

Interventions

RADIATION: reduced target volume
RADIATION: EORTC (European organisation for research and treatment of cancer) target volume

Sponsor

Zhujiang Hospital